Haibin Wu

发表

Targeting transferrin receptor delivery of temozolomide for a potential glioma stem cell-mediated therapy

Yulun Huang, T. Sun, Yanyan Li, 2017, Oncotarget.

SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway

H. Yin, T. Sun, Yanyan Li, 2017, Journal of Neuro-Oncology.

Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells

Yulun Huang, Wei Yang, T. Sun, 2019, Journal of Cancer.

MGMT autoantibodies as a potential prediction of recurrence and treatment response biomarker for glioma patients

Hongwei Ma, Yulun Huang, T. Sun, 2019, Cancer medicine.

ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling.

X. Yang, Zhengjun Chen, Quqin Lu, 2022, Neuro-oncology.

Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway

Z. Du, Youxin Zhou, Sansong Chen, 2018, Oncology reports.

Molecular mechanism of SSFA2 deletion inhibiting cell proliferation and promoting cell apoptosis in glioma.

Youxin Zhou, Xuetao Li, Fenglai Yuan, 2019, Pathology, research and practice.

EMP1 regulates cell proliferation, migration, and stemness in gliomas through PI3K‐AKT signaling and CD44

Youxin Zhou, Xuetao Li, Hao Wang, 2019, Journal of cellular biochemistry.

APOE as potential biomarkers of moyamoya disease

X. Xiong, Jian Yan, Jian Duan, 2023, Frontiers in Neurology.

Single‐cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug‐resistance mechanisms of recurrent glioblastoma

Hongmin Bai, Jian Duan, chao wang, 2023, Cancer science.